PATENT CLAIM ANALYSIS

Application Number: 15884699
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "217000"]

Abstract:
Methods of treating developmental disorders by administering a pharmaceutical composition of pipradrol or a pharmaceutically acceptable salt thereof are provided. The methods may be used to treat conditions such as epilepsy, Landau-Kleffner Syndrome, Lennox-Gastaut syndrome (LGS) and Dravet syndrome.

Claim (Index 5):
The method of  claim 1  wherein the developmental disorder is a childhood epilepsy syndrome selected from the group consisting of benign rolandic epilepsy (BRE), intractable childhood epilepsy (ICE), childhood absence epilepsy (CAE), juvenile myoclonic epilepsy (JME), infantile spasms (or West syndrome) and Lennox-Gastaut syndrome (LGS).

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15493374', '14876110', '15191068', '15680417', '14240847']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7804246255553284
- 35 USC 102 Novelty (BERT): 0.5360272587188102
- Combined Prediction Score: 0.7559848888716766
- Mean Citation Score: 331.83315
- Max Citation Score: 371.2598
- Similarity Product: 312.3570719933033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test